This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maehara, Y. Articles by Sugimachi, K. Search for Related Content PubMed PubMed Citation Articles by Maehara, Y. Articles by Sugimachi, K.

Role of Transforming Growth Factor-ß1 in Invasion and Metastasis in Gastric Carcinoma

From the Cancer Center, Department of Surgery II, and Department of Medical Informatics, Faculty of Medicine, Kyushu University; and National Kyushu Cancer Center, Fukuoka, Japan.

Address reprint requests to Yoshihiko Maehara, MD, Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan.

PURPOSE: Transforming growth factor-beta1 (TGF-ß1) is a major modulator of cellular proliferation and extracellular matrix formation. We determined the role of TGF-ß1 in invasion and metastasis in gastric cancer.

MATERIALS AND METHODS: We detected TGF-ß1 expression in primary and lymph node metastatic lesions of gastric cancer, using an antibody and in situ hybridization. The plasma TGF-ß1 levels in the peripheral vein and in the tumor drainage vein were assayed.

RESULTS: In the cytoplasm of cancer cells, TGF-ß1 was immunostained in 35.9% (78 of 217) of primary gastric carcinomas, and this expression was confirmed by in situ hybridization. Of 59 gastric carcinomas with a TGF-ß1–negative primary tumor, metastatic lymph nodes were positive for TGF-ß1 staining in 32 cases (54.2%). Positive staining of TGF-ß1 in gastric cancer tissues was closely related to serosal invasion, infiltrative growth, and lymph node metastasis. Multivariate analysis showed that the expression of TGF-ß1 was an independent risk factor for serosal invasion and infiltrative growth of the tumor. The plasma level of TGF-ß1 did not differ between TGF-ß1–negative and –positive groups. There were also no differences in plasma TGF-ß1 levels among each tumor stage, between the peripheral and the tumor drainage veins, and between preoperative and postoperative testings.

CONCLUSION: Transforming growth factor-ß1 is closely related to the invasion and metastasis of gastric cancer, and production of TGF-ß1 in the tumor does not contribute to the total amount of TGF-ß1 in the blood circulation. We interpret our observations to mean that in a tumor microenvironment, TGF-ß1 alters the biologic behavior of the tumor.

This article has been cited by other articles:

				S. McMahon, M. Charbonneau, S. Grandmont, D. E. Richard, and C. M. Dubois Transforming Growth Factor beta1 Induces Hypoxia-inducible Factor-1 Stabilization through Selective Inhibition of PHD2 Expression J. Biol. Chem., August 25, 2006; 281(34): 24171 - 24181. [Abstract] [Full Text] [PDF]

				M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400. [Abstract] [Full Text] [PDF]

				R. L. Elliott and G. C. Blobe Role of Transforming Growth Factor Beta in Human Cancer J. Clin. Oncol., March 20, 2005; 23(9): 2078 - 2093. [Abstract] [Full Text] [PDF]

				H. Okano, H. Shinohara, A. Miyamoto, K. Takaori, and N. Tanigawa Concomitant Overexpression of Cyclooxygenase-2 in HER-2-Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome Clin. Cancer Res., October 15, 2004; 10(20): 6938 - 6945. [Abstract] [Full Text] [PDF]

				H. Chang, C. W. Brown, and M. M. Matzuk Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily Endocr. Rev., December 1, 2002; 23(6): 787 - 823. [Abstract] [Full Text] [PDF]

				S. Natsugoe, C. Xiangming, M. Matsumoto, H. Okumura, S. Nakashima, H. Sakita, S. Ishigami, M. Baba, S. Takao, and T. Aikou Smad4 and Transforming Growth Factor {beta}1 Expression in Patients with Squamous Cell Carcinoma of the Esophagus Clin. Cancer Res., June 1, 2002; 8(6): 1838 - 1842. [Abstract] [Full Text] [PDF]

				N. J. P. Beasley, R. Prevo, S. Banerji, R. D. Leek, J. Moore, P. van Trappen, G. Cox, A. L. Harris, and D. G. Jackson Intratumoral Lymphangiogenesis and Lymph Node Metastasis in Head and Neck Cancer Cancer Res., March 1, 2002; 62(5): 1315 - 1320. [Abstract] [Full Text] [PDF]

				C. Xiangming, S. Natsugoe, S. Takao, S. Hokita, S. Ishigami, G. Tanabe, M. Baba, K. Kuroshima, and T. Aikou Preserved Smad4 Expression in the Transforming Growth Factor {beta} Signaling Pathway Is a Favorable Prognostic Factor in Patients with Advanced Gastric Cancer Clin. Cancer Res., February 1, 2001; 7(2): 277 - 282. [Abstract] [Full Text]

				G. C. Blobe, W. P. Schiemann, and H. F. Lodish Role of Transforming Growth Factor {beta} in Human Disease N. Engl. J. Med., May 4, 2000; 342(18): 1350 - 1358. [Full Text] [PDF]